{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:52:25Z","timestamp":1780685545618,"version":"3.54.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23554-2","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:05:14Z","timestamp":1763075114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3)"],"prefix":"10.1038","volume":"15","author":[{"given":"Kevin I.","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda B.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J.","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dami\u00e1n E.","family":"Moavro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo D.","family":"Carosella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela N.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando L.","family":"Riccillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"23554_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.gene.2005.11.004","volume":"370","author":"JM McPartland","year":"2006","unstructured":"McPartland, J. M., Matias, I., Di Marzo, V. & Glass, M. Evolutionary origins of the endocannabinoid system. Gene 370, 64\u201374. https:\/\/doi.org\/10.1016\/j.gene.2005.11.004 (2006).","journal-title":"Gene"},{"key":"23554_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/3-540-26573-2_9","volume":"168","author":"MR Elphick","year":"2005","unstructured":"Elphick, M. R. & Egertov\u00e1, M. The phylogenetic distribution and evolutionary origins of endocannabinoid signalling. Handb. Exp. Pharmacol. 168, 283\u2013297. https:\/\/doi.org\/10.1007\/3-540-26573-2_9 (2005).","journal-title":"Handb. Exp. Pharmacol."},{"issue":"7","key":"23554_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11912-016-0530-0","volume":"18","author":"SM Birdsall","year":"2016","unstructured":"Birdsall, S. M., Birdsall, T. C. & Tims, L. A. The use of medical marijuana in cancer. Curr. Oncol. Rep. 18(7), 40. https:\/\/doi.org\/10.1007\/s11912-016-0530-0 (2016).","journal-title":"Curr. Oncol. Rep."},{"issue":"3","key":"23554_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher, P., B\u00e1tkai, S. & Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58(3), 389\u2013462. https:\/\/doi.org\/10.1124\/pr.58.3.2 (2006).","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"23554_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.6004\/jnccn.2016.0094","volume":"14","author":"MP Davis","year":"2016","unstructured":"Davis, M. P. Cannabinoids for symptom management and cancer therapy: The evidence. J. Natl. Compr. Canc. Netw. 14(7), 915\u2013922. https:\/\/doi.org\/10.6004\/jnccn.2016.0094 (2016).","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"23554_CR6","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","volume":"96","author":"A Ligresti","year":"2016","unstructured":"Ligresti, A., De Petrocellis, L. & Di Marzo, V. From phytocannabinoids to cannabinoid receptors and endocannabinoids: Pleiotropic physiological and pathological roles through complex pharmacology. Physiol. Rev. 96(4), 1593\u20131659. https:\/\/doi.org\/10.1152\/physrev.00002.2016 (2016).","journal-title":"Physiol. Rev."},{"issue":"9","key":"23554_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd.2018.115","volume":"17","author":"V Di Marzo","year":"2018","unstructured":"Di Marzo, V. New approaches and challenges to targeting the endocannabinoid system. Nat. Rev. Drug. Discov. 17(9), 623\u2013639. https:\/\/doi.org\/10.1038\/nrd.2018.115 (2018).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"23554_CR8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni, Y. & Mechoulam, R. Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646\u20131647. https:\/\/doi.org\/10.1021\/ja01062a046 (1964).","journal-title":"J. Am. Chem. Soc."},{"key":"23554_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1021\/np50008a001","volume":"43","author":"CE Turner","year":"1980","unstructured":"Turner, C. E., Elsohly, M. A. & Boeren, E. G. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J. Nat. Prod. 43, 169\u2013234. https:\/\/doi.org\/10.1021\/np50008a001 (1980).","journal-title":"J. Nat. Prod."},{"key":"23554_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda, L. A. et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561\u2013564. https:\/\/doi.org\/10.1038\/346561a0 (1990).","journal-title":"Nature"},{"key":"23554_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro, S., Thomas, K. L. & Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61\u201365. https:\/\/doi.org\/10.1038\/365061a0 (1993).","journal-title":"Nature"},{"key":"23554_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-20825-1_1","author":"RG Pertwee","year":"2005","unstructured":"Pertwee, R. G. Pharmacological actions of Cannabinoids in Handb. Exp. Pharmacol. https:\/\/doi.org\/10.1007\/978-3-319-20825-1_1 (2005).","journal-title":"Exp. Pharmacol."},{"key":"23554_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrn3811","volume":"15","author":"R Mechoulam","year":"2014","unstructured":"Mechoulam, R. et al. Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat. Rev. Neurosci. 15, 757\u2013776. https:\/\/doi.org\/10.1038\/nrn3811 (2014).","journal-title":"Nat. Rev. Neurosci."},{"issue":"29\u201330","key":"23554_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3238\/arztebl.2012.0495","volume":"109","author":"F Grotenhermen","year":"2012","unstructured":"Grotenhermen, F. & M\u00fcller-Vahl, K. The therapeutic potential of cannabis and cannabinoids. Dtsch. Arztebl. Int. 109(29\u201330), 495\u2013501. https:\/\/doi.org\/10.3238\/arztebl.2012.0495 (2012).","journal-title":"Dtsch. Arztebl. Int."},{"key":"23554_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","volume":"36","author":"M Maccarrone","year":"2015","unstructured":"Maccarrone, M. et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol. Sci. 36, 277\u2013296. https:\/\/doi.org\/10.1016\/j.tips.2015.02.008 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"23554_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee, R. G. et al. International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond cb1 and cb2. Pharmacol. Rev. 62, 588\u2013631. https:\/\/doi.org\/10.1124\/pr.110.003004 (2010).","journal-title":"Pharmacol. Rev."},{"key":"23554_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154771","volume":"114","author":"S Khosropoor","year":"2023","unstructured":"Khosropoor, S., Alavi, M. S., Etemad, L. & Roohbakhsh, A. Cannabidiol goes nuclear: The role of PPAR\u03b3. Phytomedicine 114, 154771. https:\/\/doi.org\/10.1016\/j.phymed.2023.154771 (2023).","journal-title":"Phytomedicine"},{"issue":"3","key":"23554_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1476-5381.2008.00048.x","volume":"156","author":"RG Pertwee","year":"2009","unstructured":"Pertwee, R. G. Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br. J. Pharmacol. 156(3), 397\u2013411. https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00048.x (2009).","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"23554_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-010-1177-4","volume":"129","author":"SD McAllister","year":"2011","unstructured":"McAllister, S. D. et al. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res. Treat. 129(1), 37\u201347. https:\/\/doi.org\/10.1007\/s10549-010-1177-4 (2011).","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"23554_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076918","volume":"8","author":"M Solinas","year":"2013","unstructured":"Solinas, M. et al. Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect. PLoS ONE 8(10), e76918. https:\/\/doi.org\/10.1371\/journal.pone.0076918 (2013).","journal-title":"PLoS ONE"},{"issue":"5","key":"23554_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.phymed.2013.11.006","volume":"21","author":"B Romano","year":"2014","unstructured":"Romano, B. et al. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. Phytomedicine 21(5), 631\u2013639. https:\/\/doi.org\/10.1016\/j.phymed.2013.11.006 (2014).","journal-title":"Phytomedicine"},{"issue":"2","key":"23554_CR22","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.3747\/co.23.3080","volume":"23","author":"G Velasco","year":"2016","unstructured":"Velasco, G., S\u00e1nchez, C. & Guzm\u00e1n, M. Anticancer mechanisms of cannabinoids. Curr. Oncol. 23(2), S23-32. https:\/\/doi.org\/10.3747\/co.23.3080 (2016).","journal-title":"Curr. Oncol."},{"key":"23554_CR23","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3390\/molecules29091943","volume":"29","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Research progress on the mechanism of the antitumor effects of cannabidiol. Molecules 29, 1943. https:\/\/doi.org\/10.3390\/molecules29091943 (2024).","journal-title":"Molecules"},{"key":"23554_CR24","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","volume":"94","author":"N Rouas-Freiss","year":"1997","unstructured":"Rouas-Freiss, N., Gon\u00e7alves, R. M. B., Menier, C., Dausset, J. & Carosella, E. D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA. 94, 11520\u201311525. https:\/\/doi.org\/10.1073\/pnas.94.21.11520 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"9221","key":"23554_CR25","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(00)02386-2","volume":"355","author":"N Lila","year":"2000","unstructured":"Lila, N. et al. Implication of HLA-G molecule in heart-graft acceptance. The Lancet. 355(9221), 2138. https:\/\/doi.org\/10.1016\/S0140-6736(00)02386-2 (2000).","journal-title":"The Lancet."},{"issue":"3","key":"23554_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","volume":"29","author":"ED Carosella","year":"2018","unstructured":"Carosella, E. D., Moreau, P., LeMaoult, J. & Rouas-Freiss, N. HLA-G: From biology to clinical benefits. Trends Immunol. 29(3), 125\u2013132. https:\/\/doi.org\/10.1016\/j.it.2007.11.005 (2018).","journal-title":"Trends Immunol."},{"key":"23554_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/0963689721993774","author":"MB Palma","year":"2021","unstructured":"Palma, M. B. et al. Wound healing by allogeneic transplantation of specific subpopulation from human umbilical cord mesenchymal stem cells. Cell Transpl. https:\/\/doi.org\/10.1177\/0963689721993774 (2021).","journal-title":"Cell Transpl."},{"issue":"11","key":"23554_CR28","doi-asserted-by":"publisher","first-page":"e26491","DOI":"10.4161\/onci.26491","volume":"2","author":"G Kochan","year":"2013","unstructured":"Kochan, G., Escors, D., Breckpot, K. & Guerrero-Setas, D. Role of non-classical MHC class I molecules in cancer immunosuppression. OncoImmunology 2(11), e26491. https:\/\/doi.org\/10.4161\/onci.26491 (2013).","journal-title":"OncoImmunology"},{"key":"23554_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/359748","author":"N Rouas-Freiss","year":"2014","unstructured":"Rouas-Freiss, N., Moreau, P., LeMaoult, J. & Carosella, E. D. The dual role of HLA-G in cancer. J. Immunol. Res. https:\/\/doi.org\/10.1155\/2014\/359748 (2014).","journal-title":"J. Immunol. Res."},{"issue":"11","key":"23554_CR30","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/1878-0261.12119","volume":"11","author":"D Tronik-Le Roux","year":"2017","unstructured":"Tronik-Le Roux, D. et al. Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients. Mol. Oncol. 11(11), 1561\u20131578. https:\/\/doi.org\/10.1002\/1878-0261.12119 (2017).","journal-title":"Mol. Oncol."},{"key":"23554_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-022-00918-y","volume":"7","author":"X Xiong","year":"2022","unstructured":"Xiong, X. et al. Cannabis suppresses antitumor immunity by inhibiting JAK\/STAT signaling in T cells through CNR2. Signal Transduct. Targeted Ther. 7, 99. https:\/\/doi.org\/10.1038\/s41392-022-00918-y (2022).","journal-title":"Signal Transduct. Targeted Ther."},{"key":"23554_CR32","doi-asserted-by":"publisher","unstructured":"Dada, S., Ellis, S. L. S., Wood, C., Nohara, L. L., Dreier, C., Garcia, N. H., Saranchova, I., Munro, L., Pfeifer, C. G., Eyford, B. A., Kari, S., Garrovillas, E., Caspani, G., al Haddad, E., Gray, P. W., Morova, T., Lack, N. A., Andersen, R. J., Tjoelker, L., & Jefferies, W. A. Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours. Front. Immunol., https:\/\/doi.org\/10.3389\/fimmu.2022.982082 (2022).","DOI":"10.3389\/fimmu.2022.982082"},{"issue":"7","key":"23554_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jpha.2023.04.013","volume":"13","author":"X Sun","year":"2023","unstructured":"Sun, X. et al. Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer. J. Pharmac. Anal. 13(7), 726\u2013744. https:\/\/doi.org\/10.1016\/j.jpha.2023.04.013 (2023).","journal-title":"J. Pharmac. Anal."},{"key":"23554_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.phymed.2017.08.026","volume":"50","author":"S Park","year":"2018","unstructured":"Park, S., Lim, W., Bazer, F. W. & Song, G. Naringenin suppresses growth of human placental choriocarcinoma via reactive oxygen species-mediated P38 and JNK MAPK pathways. Phytomedicine 50, 238\u2013246. https:\/\/doi.org\/10.1016\/j.phymed.2017.08.026 (2018).","journal-title":"Phytomedicine"},{"key":"23554_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2017.04.014","volume":"399","author":"C Yang","year":"2017","unstructured":"Yang, C., Lim, W., Bazer, F. W. & Song, G. Myricetin suppresses invasion and promotes cell death in human placental choriocarcinoma cells through induction of oxidative stress. Cancer Lett. 399, 10\u201319. https:\/\/doi.org\/10.1016\/j.canlet.2017.04.014 (2017).","journal-title":"Cancer Lett."},{"issue":"6","key":"23554_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrc3247","volume":"12","author":"G Velasco","year":"2012","unstructured":"Velasco, G., S\u00e1nchez, C. & Guzm\u00e1n, M. Towards the use of cannabinoids as antitumour agents. Nat. Rev. Cancer 12(6), 436\u2013444. https:\/\/doi.org\/10.1038\/nrc3247 (2012).","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"23554_CR37","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1096\/fj.11-198184","volume":"26","author":"R Ramer","year":"2012","unstructured":"Ramer, R. et al. Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J. 26(4), 1535\u20131548. https:\/\/doi.org\/10.1096\/fj.11-198184 (2012).","journal-title":"FASEB J."},{"issue":"11","key":"23554_CR38","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1158\/1535-7163.MCT-07-0371","volume":"6","author":"SD McAllister","year":"2007","unstructured":"McAllister, S. D., Christian, R. T., Horowitz, M. P., Garcia, A. & Desprez, P. Y. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Mol. Cancer Ther. 6(11), 2921\u20132927. https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-0371 (2007).","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"23554_CR39","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1007\/s11033-022-08197-0","volume":"50","author":"LR Motadi","year":"2023","unstructured":"Motadi, L. R., Jantjies, Z. E. & Moleya, B. Cannabidiol and Cannabis Sativa as a potential treatment in vitro prostate cancer cells silenced with RBBp6 and PC3 xenograft. Mol. Biol. Rep. 50(5), 4039\u20134047. https:\/\/doi.org\/10.1007\/s11033-022-08197-0 (2023).","journal-title":"Mol. Biol. Rep."},{"issue":"13","key":"23554_CR40","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1158\/0008-5472.CAN-06-0169","volume":"66","author":"A Carracedo","year":"2006","unstructured":"Carracedo, A. et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Can. Res. 66(13), 6748\u20136755. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0169 (2006).","journal-title":"Can. Res."},{"issue":"4","key":"23554_CR41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/bcpt.13710","volume":"130","author":"J Peng","year":"2022","unstructured":"Peng, J. et al. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin. Pharmacol. Toxicol. 130(4), 439\u2013456. https:\/\/doi.org\/10.1111\/bcpt.13710 (2022).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"23554_CR42","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1124\/jpet.103.061002","volume":"308","author":"P Massi","year":"2004","unstructured":"Massi, P. et al. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. J. Pharmacol. Exp. Ther. 308(3), 838\u2013845. https:\/\/doi.org\/10.1124\/jpet.103.061002 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"23554_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0198-8859(00)00097-5","volume":"61","author":"T Cabrera","year":"2000","unstructured":"Cabrera, T. et al. High frequency of altered HLA class I phenotypes in laryngeal carcinomas. Hum. Immunol. 61, 499\u2013506. https:\/\/doi.org\/10.1016\/S0198-8859(00)00097-5 (2000).","journal-title":"Hum. Immunol."},{"issue":"5","key":"23554_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00262-006-0226-7","volume":"56","author":"T Cabrera","year":"2007","unstructured":"Cabrera, T. et al. HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination. Cancer Immunol. Immunother. 56(5), 709\u2013717. https:\/\/doi.org\/10.1007\/s00262-006-0226-7 (2007).","journal-title":"Cancer Immunol. Immunother."},{"key":"23554_CR45","doi-asserted-by":"publisher","first-page":"1165813","DOI":"10.3389\/fimmu.2023.1165813","volume":"14","author":"J Bartolome","year":"2023","unstructured":"Bartolome, J. et al. Prognostic value of human leukocyte antigen G expression in solid tumors: A systematic review and meta-analysis. Front. Immunol. 14, 1165813. https:\/\/doi.org\/10.3389\/fimmu.2023.1165813 (2023).","journal-title":"Front. Immunol."},{"key":"23554_CR46","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.semcancer.2012.03.003","volume":"22","author":"J Bukur","year":"2012","unstructured":"Bukur, J., Jasinski, S. & Seliger, B. The role of classical and non-classical HLA class I antigens in human tumors. Semin. Cancer Biol. 22, 350\u2013358. https:\/\/doi.org\/10.1016\/j.semcancer.2012.03.003 (2012).","journal-title":"Semin. Cancer Biol."},{"key":"23554_CR47","doi-asserted-by":"publisher","unstructured":"Benitez Fuentes, J. D., Bartolome Arcilla, J., Mohamed Mohamed, K., Lopez de Sa, A., de Luna Aguilar, A., Guevara-Hoyer, K., Ballestin Martinez, P., Lazaro Sanchez, A. D., Carosella, E. D., Oca\u00f1a, A., & S\u00e1nchez-Ramon, S. Targeting of non-classical human leukocyte antigens as novel therapeutic strategies in cancer. Cancers https:\/\/doi.org\/10.3390\/cancers16244266, (2024).","DOI":"10.3390\/cancers16244266"},{"issue":"42","key":"23554_CR48","doi-asserted-by":"publisher","first-page":"39525","DOI":"10.1074\/jbc.M112273200","volume":"277","author":"SJ Gobin","year":"2002","unstructured":"Gobin, S. J., Biesta, P., de Steenwinkel, J. E., Datema, G. & van den Elsen, P. J. HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes. J. Biol. Chem. 277(42), 39525\u201339531. https:\/\/doi.org\/10.1074\/jbc.M112273200 (2002).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"23554_CR49","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12967-020-02544-0","volume":"18","author":"M Friedrich","year":"2020","unstructured":"Friedrich, M. et al. Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma. J. Transl. Med. 18(1), 371. https:\/\/doi.org\/10.1186\/s12967-020-02544-0 (2020).","journal-title":"J. Transl. Med."},{"key":"23554_CR50","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2147\/JPR.S258433","volume":"13","author":"U Anand","year":"2020","unstructured":"Anand, U. et al. CBD effects on TRPV1 signaling pathways in cultured DRG neurons. J. Pain Res. 13, 2269\u20132278. https:\/\/doi.org\/10.2147\/JPR.S258433 (2020).","journal-title":"J. Pain Res."},{"issue":"5","key":"23554_CR51","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3724\/abbs.2024183","volume":"57","author":"Y Cao","year":"2025","unstructured":"Cao, Y. et al. Cannabidiol alleviates the inflammatory response in rats with traumatic brain injury through the PGE2-EP2-cAMP-PKA signaling pathway. Acta Biochim. Biophys. Sin. 57(5), 758\u2013769. https:\/\/doi.org\/10.3724\/abbs.2024183 (2025).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"23554_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101247","volume":"81","author":"S Wang","year":"2025","unstructured":"Wang, S. et al. PARP inhibition elicits NK cell-associated immune evasion via potentiating HLA-G expression in tumor. Drug Resist. Updates Rev. Comment. Antimicrob. Anticancer Chemother. 81, 101247. https:\/\/doi.org\/10.1016\/j.drup.2025.101247 (2025).","journal-title":"Drug Resist. Updates Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"6","key":"23554_CR53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jtcme.2024.04.007","volume":"14","author":"T Pongking","year":"2024","unstructured":"Pongking, T. et al. Cannabidiol suppresses proliferation and induces cell death, autophagy and senescence in human cholangiocarcinoma cells via the PI3K\/AKT\/mTOR pathway. J. Tradit. Complement Med. 14(6), 622\u2013634. https:\/\/doi.org\/10.1016\/j.jtcme.2024.04.007 (2024).","journal-title":"J. Tradit. Complement Med."},{"key":"23554_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/734068","volume":"2014","author":"EC Castelli","year":"2014","unstructured":"Castelli, E. C., Veiga-Castelli, L. C., Yaghi, L., Moreau, P. & Donadi, E. A. Transcriptional and post-transcriptional regulations of the HLA-G gene. J. Immunol. Res. 2014, 734068. https:\/\/doi.org\/10.1155\/2014\/734068 (2014).","journal-title":"J. Immunol. Res."},{"issue":"352","key":"23554_CR55","doi-asserted-by":"publisher","first-page":"104110","DOI":"10.1016\/j.cellimm.2020.104110","volume":"1","author":"G Persson","year":"2020","unstructured":"Persson, G. et al. Cytokine stimulation of the choriocarcinoma cell line JEG-3 leads to alterations in the HLA-G expression profile. Cell. Immunol. 1(352), 104110. https:\/\/doi.org\/10.1016\/j.cellimm.2020.104110 (2020).","journal-title":"Cell. Immunol."},{"key":"23554_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103214","volume":"146","author":"Q Geng","year":"2024","unstructured":"Geng, Q. et al. PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis. J. Autoimmun. 146, 103214. https:\/\/doi.org\/10.1016\/j.jaut.2024.103214 (2024).","journal-title":"J. Autoimmun."},{"key":"23554_CR57","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/npp.2017.209","volume":"43","author":"DL Boggs","year":"2017","unstructured":"Boggs, D. L., Nguyen, J. D., Morgenson, D., Taffe, M. A. & Ranganathan, M. Clinical and preclinical evidence for functional interactions of cannabidiol and delta (9)-Tetrahydrocannabinol. Neuropsychopharmacology 43, 142\u2013154. https:\/\/doi.org\/10.1038\/npp.2017.209 (2017).","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"23554_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00262-024-03801-7","volume":"73","author":"K Dickinson","year":"2024","unstructured":"Dickinson, K., Yee, E. J., Vigil, I., Schulick, R. D. & Zhu, Y. GPCRs: emerging targets for novel T cell immune checkpoint therapy. Cancer Immunol. Immunother. 73(12), 253. https:\/\/doi.org\/10.1007\/s00262-024-03801-7 (2024).","journal-title":"Cancer Immunol. Immunother."},{"key":"23554_CR59","doi-asserted-by":"publisher","first-page":"1497829","DOI":"10.3389\/fimmu.2025.1497829","volume":"16","author":"M Vigano","year":"2025","unstructured":"Vigano, M. et al. Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy. Front. Immunol. 16, 1497829. https:\/\/doi.org\/10.3389\/fimmu.2025.1497829 (2025).","journal-title":"Front. Immunol."},{"key":"23554_CR60","doi-asserted-by":"publisher","first-page":"1268652","DOI":"10.3389\/fimmu.2024.1268652","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells. Front. Immunol. 15, 1268652. https:\/\/doi.org\/10.3389\/fimmu.2024.1268652 (2024).","journal-title":"Front. Immunol."},{"key":"23554_CR61","doi-asserted-by":"publisher","first-page":"1528520","DOI":"10.3389\/fimmu.2025.1528520","volume":"16","author":"P Sen","year":"2025","unstructured":"Sen, P. et al. CBD promotes antitumor activity by modulating tumor immune microenvironment in HPV associated head and neck squamous cell carcinoma. Front. Immunol. 16, 1528520. https:\/\/doi.org\/10.3389\/fimmu.2025.1528520 (2025).","journal-title":"Front. Immunol."},{"issue":"20","key":"23554_CR62","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie, R. B., Bagher, A. M., Kelly, M. E. & Denovan-Wright, E. M. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br. J. Pharmacol. 172(20), 4790\u20134805. https:\/\/doi.org\/10.1111\/bph.13250 (2015).","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"23554_CR63","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/bph.14440","volume":"176","author":"M Tham","year":"2019","unstructured":"Tham, M. et al. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Br. J. Pharmacol. 176(10), 1455\u20131469. https:\/\/doi.org\/10.1111\/bph.14440 (2019).","journal-title":"Br. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23554-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:05:15Z","timestamp":1763075115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23554-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23554"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23554-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures were conducted in accordance with relevant guidelines and regulations (the ethical standards of the 1964 Declaration of Helsinki) and were approved by the ethics committee COBIMED (Comit\u00e9 de Bio\u00e9tica y Etica de la Investigaci\u00f3n de la Facultad de Ciencias M\u00e9dicas de la Universidad de La Plata).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"39808"}}